Research progress on atypical anti-glomerular basement membrane disease |
Received:January 15, 2020 Revised:February 07, 2020 Click here to download the full text |
Citation of this paper:CAO Pei-yang,YANG Jing,LU Guo-yuan.Research progress on atypical anti-glomerular basement membrane disease[J].Chinese Journal of Clinical Medicine,2020,27(3):524-527 |
Hits: 1512 |
Download times: 821 |
Author Name | Affiliation | E-mail | CAO Pei-yang | Department of Nephrology, the First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu, China | | YANG Jing | Department of Nephrology, the First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu, China | | LU Guo-yuan | Department of Nephrology, the First Affiliated Hospital of Soochow University, Suzhou 215006, Jiangsu, China | sdfyylgy@163.com |
|
Abstract:Anti-glomerular basement membrane disease is an autoimmune disease with low incidence but severe clinical symptoms. With the development of diagnosis and related technologies, it is found that in patients with anti-glomerular basement membrane disease, the clinical manifestations and laboratory examination results of some patients are different from those of typical patients in the process of clinical diagnosis. The pathogenesis of such patients with anti-glomerular basement membrane disease are not clear and the clinical manifestations are not typical, it brings some difficulties to clinical diagnosis and there is no uniform standard for its treatment at present. This article will review the research progress of atypical anti-glomerular basement membrane disease. |
keywords:anti-glomerular basement membrane disease pathogenesis anti-glomerular basement membrane antibody therapy method |
HTML View Full Text View/Add Comment Download reader |
|
|
|